Equities

Aster DM Healthcare Ltd

ASTERDM:NSI

Aster DM Healthcare Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)432.30
  • Today's Change4.30 / 1.00%
  • Shares traded544.41k
  • 1 Year change+28.05%
  • Beta1.2320
Data delayed at least 15 minutes, as of Nov 22 2024 10:17 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Aster DM Healthcare Ltd had net income fall -69.57% from 4.25bn to 1.29bn despite a 23.54% increase in revenues from 29.94bn to 36.99bn. An increase in the selling, general and administrative costs as a percentage of sales from 33.50% to 33.86% was a component in the falling net income despite rising revenues.
Gross margin40.82%
Net profit margin19.40%
Operating margin21.78%
Return on assets2.85%
Return on equity6.43%
Return on investment4.16%
More ▼

Cash flow in INRView more

In 2024, Aster DM Healthcare Ltd increased its cash reserves by 91.05%, or 3.32bn. Cash Flow from Financing totalled 10.53bn or 28.46% of revenues. In addition the company generated 1.58bn in cash from operations while cash used for investing totalled 8.85bn.
Cash flow per share7.64
Price/Cash flow per share54.75
Book value per share68.98
Tangible book value per share63.05
More ▼

Balance sheet in INRView more

Aster DM Healthcare Ltd has a Debt to Total Capital ratio of 35.01%, a lower figure than the previous year's 102.55%.
Current ratio1.93
Quick ratio1.82
Total debt/total equity0.5648
Total debt/total capital0.3501
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items increased 12.26%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)39.68%
EPS growth(5 years)-17.99
EPS (TTM) vs
TTM 1 year ago
556.65
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.